Marcus Jonathan L's Form 4/A amendment
AmendedCME Group Inc.CME · filed Mar 23, 2026
- Accession no.
- 0001628280-26-020364
- Filed
- Mar 23, 2026
- Trade date
- Mar 17, 2026
- Filing delay
- 6 days
- Rule 10b5-1 plan
- Checked
- Original filed
- Mar 19, 2026
This filing lists 1 non-derivative transaction. Open-market sales total $1.03M. It was filed 6 days after the trade.
This amendment replaces 0001628280-26-019658 (filed Mar 19, 2026).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Marcus Jonathan LCIK 0001952996 | Officer (Sr MD General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | Common Stock Class A | SSaleDisposed | −3,291 | $313.37F2 | −$1,031,300.67 | 7,192 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 18, 2025.
- F2
This amendment is being filed to correct the price per share of the common stock sold on March 17, 2026, which was incorrectly reported on the original Form 4 filed on March 19, 2026 due to a clerical error. All other information in the original Form 4 remains unchanged.
Referenced by the price of 1 transaction in Table I.